| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/16/2008 | CN101220028A Urea substituted imidazopyridines |
| 07/16/2008 | CN101220027A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 07/16/2008 | CN101220025A Micronized crystalline tiotropium bromide |
| 07/16/2008 | CN101219985A N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action |
| 07/16/2008 | CN101219163A Method for preparing confinement water |
| 07/16/2008 | CN101219154A Microorganism additive agent for improving phylactic power of pets and accelerating growth |
| 07/16/2008 | CN101219145A Quinazoline derivatives as VEGF inhibitors |
| 07/16/2008 | CN100402642C Method and apparatus or maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 07/16/2008 | CN100402580C Modified bio-related substance, process for producing the same, and intermediate |
| 07/16/2008 | CN100402549C Bridged bicyclic serine protease inhibitors |
| 07/16/2008 | CN100402530C Pyrimidotriazines as phosphatase inhibitors |
| 07/16/2008 | CN100402528C Urea substituted imidazopyridines |
| 07/16/2008 | CN100402521C 4-imidazolin-2-one compounds |
| 07/16/2008 | CN100402517C 9-anthrone lactone compounds, preparing method and use thereof |
| 07/16/2008 | CN100402510C Oxazole derivatives and their use as insulin sensitizers |
| 07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
| 07/16/2008 | CN100402497C Fluorinated vitamin D3 analogs |
| 07/16/2008 | CN100402054C Medicine for treating heatstroke and its preparation method |
| 07/16/2008 | CN100402042C Composition and method for augmenting kidney function |
| 07/16/2008 | CN100402032C Tetrahydroquinoline analogues as muscarinic agonists |
| 07/16/2008 | CN100402029C Combinations comprising epothilone derivatives and alkylating agent |
| 07/16/2008 | CN100402025C Modified release pharmaceutical formulation |
| 07/16/2008 | CN100402024C Gingko lactone freeze dried powder injection and its preparation method |
| 07/16/2008 | CN100402020C Medicinal formulation in particular for treating herniated invertebral discs |
| 07/15/2008 | US7399901 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease |
| 07/15/2008 | US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists |
| 07/15/2008 | US7399763 and highly specific HIV replication inhibitor; ethyl 2-benzyl-8-hydroxy-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2- alpha ]pyrazine-7-carboxylate; aquired immune deficiency syndrome (AIDS) |
| 07/15/2008 | US7399761 Phthalazine derivatives with angiogenesis inhibiting activity |
| 07/15/2008 | US7399759 1, 3-benzothiazinone derivatives and use thereof |
| 07/15/2008 | US7399745 polypeptides, fragments and/or variants, used for treatment of metabolic disorders, such as diabetes and obesity; hypoglycemic agents |
| 07/15/2008 | US7399605 Generating preferential polymerase in sample; obtain nucleotide sequences, incubate in reaction mixture, translate nucleotide sequences, recover polypeptide |
| 07/15/2008 | US7399595 Means for the diagnosis and therapy of CTCL |
| 07/15/2008 | US7399472 Vaccines |
| 07/15/2008 | CA2480583C Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
| 07/15/2008 | CA2421120C Quinolinone derivatives as tyrosine kinase inhibitors |
| 07/15/2008 | CA2407606C Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents |
| 07/15/2008 | CA2361237C Lyophilisates having improved reconstitutibility |
| 07/15/2008 | CA2315258C Neuroprotective agents |
| 07/15/2008 | CA2279620C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4) |
| 07/15/2008 | CA2274149C Peptides and compounds that bind to a receptor |
| 07/15/2008 | CA2247848C Nitric oxide donors capable of reducing toxicity from drugs |
| 07/15/2008 | CA2208605C 14.alpha.,17.alpha.-c2-bridged 19-nor-progesterone derivatives |
| 07/15/2008 | CA2113023C Tnf receptor promoter |
| 07/10/2008 | WO2008082017A1 Cyclic sulfonium salt, method for production of cyclic sulfonium salt, and glycosidase inhibitor |
| 07/10/2008 | WO2008081937A1 Protein toxin secretion inhibitor |
| 07/10/2008 | WO2008081934A1 Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same |
| 07/10/2008 | WO2008081928A1 Pyrazolopyrimidine compound |
| 07/10/2008 | WO2008081914A1 Novel aminopyrimidine derivative as plk1 inhibitor |
| 07/10/2008 | WO2008081910A1 Novel aminopyrimidine derivatives as plk1 inhibitors |
| 07/10/2008 | WO2008081537A1 Aromatic amino acid derivative with lat1 inhibitory activity, lat1 inhibitor containing the same and method for producing the same |
| 07/10/2008 | WO2008081463A2 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
| 07/10/2008 | WO2008080955A1 Isosorbide mononitrate derivatives for the treatment of intestinal disorders |
| 07/10/2008 | WO2008080939A1 Isosorbide mononitrate derivatives for the treatment of ocular hypertension |
| 07/10/2008 | WO2008080268A1 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors |
| 07/10/2008 | WO2002102229A9 Diagnosing tumorigenicity and determining resistance to anticancer therapy |
| 07/10/2008 | WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling |
| 07/10/2008 | US20080168573 Transgenic worms for use as bioreactor for expression of carboxylesterase-1for use in treatment of alzheimer's disease |
| 07/10/2008 | US20080167471 comprising 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]- alpha , alpha -dimethylbenzeneacetic acid hydrochloride; antiallergic agents and bronchodilators |
| 07/10/2008 | US20080167469 Preparing anhydrous 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride by azeotropic distillation of the corresponding hydrate |
| 07/10/2008 | US20080167457 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/10/2008 | US20080167444 Abc Transporter Inhibitor |
| 07/10/2008 | US20080167386 Anticarcinogenic and antiproliferative agents; drug screening; inhibiting Dvl-mediated Wnt signaling |
| 07/10/2008 | US20080167385 Crystal Structure of Human Proliferating Cell Nuclear Antigen (Pcna) and Uses Thereof |
| 07/10/2008 | US20080167367 Stable hydrate of a muscarinic receptor antagonist |
| 07/10/2008 | US20080167366 Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug |
| 07/10/2008 | US20080167365 Of the ACE inhibitor ramipril by mixing with the ramipril (m)ethyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
| 07/10/2008 | US20080167329 3,4-Dihydroquinazolin-2(1H)-ones, e.g., 4-Ethyl-6-chloro-4-phenyl-3-(2,2,2-trifluoroethyl)-3,4-dihydroquinazolin-2(1H)-one; treatment of epilepsy, pain, movement disorders, cognitive disorders, psychological disorders, sleep disorders, hot flashes, fibromyalgia, and drug withdrawl |
| 07/10/2008 | US20080167318 Pharmaceutically active pyrrolidine derivatives |
| 07/10/2008 | US20080167316 6-Heteroaryl-1,2,3,4,4A, 10B-Hexahydrophenanthridines as Pde4-Inhibitors for the Treatment of Inflammatory Disorders |
| 07/10/2008 | US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders |
| 07/10/2008 | US20080167301 Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as Pde4 Inhibitors |
| 07/10/2008 | US20080167300 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases |
| 07/10/2008 | US20080167280 Enhanced drug delivery in transdermal systems |
| 07/10/2008 | US20080167267 Agent for Drug Clearance and Accelerator for Drug Clearance |
| 07/10/2008 | US20080167259 Incorporating polynucleotides encoding fusion proteins comprising CFTR peptide and DNA binding domain of transcriptional activator that binds to site on detectable gene into host cell ; gene expressing; drug screening, high throughput assay; enhances dimerization of CFTR protein; cystic fibrosis |
| 07/10/2008 | US20080167256 Double-stranded RNA (siRNA) capable of suppressing expression of Skp-2 gene; small cell lung cancer |
| 07/10/2008 | US20080167245 Novel metastasis suppressor gene on human chromosome 8 |
| 07/10/2008 | US20080167240 Albumin Fusion Proteins |
| 07/10/2008 | US20080167239 Albumin Fusion Proteins |
| 07/10/2008 | US20080167238 Albumin Fusion Proteins |
| 07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
| 07/10/2008 | US20080167224 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
| 07/10/2008 | US20080167218 stability and uniformity of a PEGylated G-CSF polypeptide having at least one PEG moiety attached to the epsilon amino group of a lysine residue or the N-terminal amino group and at least one PEG moiety attached to a hydroxyl group |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/10/2008 | US20080166743 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 07/10/2008 | US20080166730 Therapeutic and diagnostic proteins comprising a SOCS box |
| 07/10/2008 | US20080166724 VEGF-Modulated Genes and Methods Employing Them |
| 07/10/2008 | US20080166709 MARKs as Modifiers of the p53 Pathway and Methods of Use |
| 07/10/2008 | US20080166434 Once daily time release formulation containing green and oolong tea extract |
| 07/10/2008 | US20080166417 Method of Relieving or Avoiding Side Effect of Steroid |
| 07/10/2008 | US20080166391 Zero-order prolonged release coaxial implants |
| 07/10/2008 | US20080166382 Amphiphilic block copolymers and nanoparticles comprising the same |
| 07/10/2008 | US20080166374 Formulating an anti-cancer vaccine comprising an agent that can stimulate an immune response against IL-13R alpha 2 outside of the subject, and administering the vaccine to the subject |
| 07/10/2008 | US20080166361 Monoclonal antibody conjugate for targeting 10-boron to tumor cells; boron neutron capture therapy |
| 07/10/2008 | US20080166353 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders |
| 07/10/2008 | US20080166349 Method to Inhibit the Propagation of an Undesired Cell Population |
| 07/10/2008 | US20080166343 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 07/10/2008 | US20080166338 Il-21 as a regulator of immunoglobin production |